Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Furthermore, the decrease expression of the antioxidant genes SOD2 (Fig
Luo, L., Li, J., Wu, Y., Qiao, J
This function boosts the production of repair enzymes, leading to faster healing
We prioritize speed and reliability to keep your project timelines on track.
For the most stable baseline, schedule routine bloodwork during the early follicular phase (days 35 after your period starts)
